WO2025136324 - A TABLET COMPOSITION COMPRISING IVACAFTOR
National phase entry is expected:
Publication Number
WO/2025/136324
Publication Date
26.06.2025
International Application No.
PCT/TR2024/051601
International Filing Date
17.12.2024
Title **
[English]
A TABLET COMPOSITION COMPRISING IVACAFTOR
[French]
COMPOSITION DE COMPRIMÉ COMPRENANT DE L'IVACAFTOR
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
ATAK, Fadime Bilgehan
GULER, Tolga
KIR, Ufuk
GOKSEN, Elif
Priority Data
2023/017799
20.12.2023
TR
2024/005912
15.05.2024
TR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2096 | |
| EPO | Filing, Examination, Granting | 9209 | |
| Japan | Filing, Examination, Granting | 2109 | |
| South Korea | Filing, Examination, Granting | 2017 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,171
Contact Us
Abstract[English]
The present invention relates to a tablet composition comprising an intragranular phase and an extragranular phase, wherein the intragranular phase comprising ivacaftor and the extragranular phase comprising at least two surfactants. The present invention also relates to a simple, rapid, cost-effective, time-saving and industrially suitable process for the preparation of a tablet composition.[French]
La présente invention concerne une composition de comprimé comprenant une phase intragranulaire et une phase extragranulaire, la phase intragranulaire comprenant de l'ivacaftor et la phase extragranulaire comprenant au moins deux tensioactifs. La présente invention concerne également un procédé simple, rapide, économique, économe en temps et industriellement approprié pour la préparation d'une composition de comprimé.